Dopaminergic neurotransmission in patients with Parkinson’s disease and impulse control disorders: a systematic review and meta-analysis of PET and SPECT studies
(2018)
Journal Article
Martini, A., Dal Lago, D., Edelstyn, N., Salgarello, M., Lugoboni, F., & Tamburin, S. (2018). Dopaminergic neurotransmission in patients with Parkinson’s disease and impulse control disorders: a systematic review and meta-analysis of PET and SPECT studies. Frontiers in Neurology, https://doi.org/10.3389/fneur.2018.01018
Background Around 30% Parkinson’s disease (PD) patients develop impulse control disorders (ICDs) to D2/3 dopamine agonists and, to a lesser extent, levodopa. We aim to investigate striatal dopaminergic function in PD patients with and without ICD.... Read More about Dopaminergic neurotransmission in patients with Parkinson’s disease and impulse control disorders: a systematic review and meta-analysis of PET and SPECT studies.